First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic

•The rates of neonatal hepatitis B vaccination were not statistically significantly different before (92.3 %) or during (90.9 %) the COVID pandemic.•91.6 % of neonates born at the study site were vaccinated for hepatitis B from 11/1/2018 through 6/30/2021.•The study institution has an order set for...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2023-04, Vol.41 (17), p.2824-2828
Main Authors: Dugovich, Anna M., Cox, Toby H., Weeda, Erin R., Garner, Sandra S.
Format: Article
Language:English
Subjects:
Babies
Birth weight
Confidence intervals
Coronaviruses
COVID-19
COVID-19 - prevention & control
COVID-19 vaccines
Disease transmission
Erythromycin
Female
Gestational age
Health care facilities
Hepatitis
Hepatitis B
Hepatitis B - epidemiology
Hepatitis B - prevention & control
Hepatitis B Vaccines
Hispanic people
Humans
Immunization
Immunoglobulins
Infant
Infant, Newborn
Infants
Mothers
Neonates
Newborn babies
Pandemics
Pandemics - prevention & control
Public health
Retrospective Studies
Steroids
Vaccination
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The rates of neonatal hepatitis B vaccination were not statistically significantly different before (92.3 %) or during (90.9 %) the COVID pandemic.•91.6 % of neonates born at the study site were vaccinated for hepatitis B from 11/1/2018 through 6/30/2021.•The study institution has an order set for key birth interventions (hepatitis B vaccination, vitamin K injection, and erythromycin eye ointment) that is used for all neonates which may have contributed to the high vaccination rate.•Factors associated with suboptimal vaccination included being of non-Hispanic white race, born to a married mother, birth weight 
ISSN:0264-410X
1873-2518
1873-2518
DOI:10.1016/j.vaccine.2023.03.039